Hang Lee
Harvard University · 639 works · 40,787 citations · h-index 101
Top works
- Trends in College Binge Drinking During a Period of Increased Prevention Efforts: Findings from 4 Harvard School of Public Health College Alcohol Study Surveys: 1993–2001
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- Insulin Sensitivity during Combined Androgen Blockade for Prostate Cancer
- Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
- Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults
- Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
- Fracture Prevalence among Human Immunodeficiency Virus (HIV)-InfectedVersusNon-HIV-Infected Patients in a Large U.S. Healthcare System
- Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk
- NIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigrees
- B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
- Measurement of Free Testosterone in Normal Women and Women with Androgen Deficiency: Comparison of Methods
- Environmental correlates of underage alcohol use and related problems of college students
- Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men
- Genome scan of European-American schizophrenia pedigrees: Results of the NIMH genetics initiative and millennium consortium
- Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer
- Reversal of Idiopathic Hypogonadotropic Hypogonadism